Type 2 diabetes numbers drive surge in insulin demand and millions could be left without
- The world will need 20 per cent more insulin by 2030 and half of those in need won’t get it unless supply improves
- A natural hormone, insulin is costly to produce and many diabetics from developing countries can’t afford treatment
A global diabetes epidemic is fuelling record demand for insulin, but tens of millions will not get the injections they need unless there is a dramatic improvement in access and affordability, a new study concluded.
Diabetes – which can lead to blindness, kidney failure, heart problems, neuropathic pain and amputation – now affects 9 per cent of all adults worldwide, up from 5 per cent in 1980.
The vast majority have type 2 diabetes, linked to obesity and lack of exercise, and numbers are increasing particularly rapidly in the developing world as people adopt more Western, urban lifestyles.
Researchers say the amount of insulin needed to effectively treat type 2 diabetes will rise by more than 20 per cent over the next 12 years; but insulin would be beyond the reach of half the 79 million type 2 diabetics predicted by that time.
The shortfall is most acute in Africa, where the team led by Dr Sanjay Basu from Stanford University estimated supply would have to rise sevenfold to treat at-risk patients who had reached the stage of requiring insulin to control their blood sugar.
